APA (7th ed.) Citation

R, K., A, K., G, M., I, K., P, B., V, P., & VB, S. (2026). A real-world study of the effectiveness and safety of low-dose immunotherapy in addition to oral metronomic chemotherapy in recurrent and metastatic head and neck squamous cell carcinoma. Journal of the Egyptian National Cancer Institute, 38(1), . https://doi.org/10.1186/s43046-026-00356-9

Chicago Style (17th ed.) Citation

R, Kothari, Khadela A, Modi G, Khatwani I, Bhatt P, Patel V, and Shah VB. "A Real-world Study of the Effectiveness and Safety of Low-dose Immunotherapy in Addition to Oral Metronomic Chemotherapy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma." Journal of the Egyptian National Cancer Institute 38, no. 1 (2026). https://doi.org/10.1186/s43046-026-00356-9.

MLA (9th ed.) Citation

R, Kothari, et al. "A Real-world Study of the Effectiveness and Safety of Low-dose Immunotherapy in Addition to Oral Metronomic Chemotherapy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma." Journal of the Egyptian National Cancer Institute, vol. 38, no. 1, 2026, https://doi.org/10.1186/s43046-026-00356-9.